Human CATR1 CRISPR gRNA in Lenti Particles
This is a CATR Tumorigenicity Conversion 1 plasmid with gRNA insert cloned into Lentiviral VectorpLenti-U6-sgRNA-PGK-Neo. Insert length: not_set. Stable, Transient expression. Suitable for GEEN and PExp.
Bacterial selection: Ampicillin.
Catalog No. ABIN5179221
$1,511.06
Plus shipping costs $50.00, if applicable $20.00 dry ice
3 x 300 μL
Shipping to:
United States
Delivery in 31 to 42 Business Days
Quick Overview for Human CATR1 CRISPR gRNA in Lenti Particles (ABIN5179221)
Gene
CATR1
(CATR Tumorigenicity Conversion 1 (CATR1))
Application
Genome Editing with Engineered Nucleases (GEEN), Protein Expression (PExp)
Insert
gRNA
Vector
Lentiviral Vector
Vector Backbone
pLenti-U6-sgRNA-PGK-Neo
Promoter
U6 Promoter, PGK Promoter
Bacterial Resistance
Ampicillin
Expression Type
Stable, Transient
-
-
Species
- Human
-
Purpose
- Set of 3 gRNA against CATR1 in Lentiviral Particles with a Titer of >1x10e7 IU/mL. (Cas9 required separately)
-
Sequence
- Sequence available upon placing order
-
Specificity
- GRNAs are designed for use with Cas9 Nuclease only.
-
Components
- Lentiviral particles with a set of 3 gRNAs (3 x 300 μL) covering different sequences of CATR1
-
Selectable Marker
- Neomycin
-
-
-
-
Application Notes
- Recommended for quality control: Restriction Enzyme Digest and Sequencing
-
Restrictions
- For Research Use only
-
-
-
Format
- Viral Particles
-
Storage
- -80 °C
-
Expiry Date
- 12 months
-
-
- CATR1 (CATR Tumorigenicity Conversion 1 (CATR1))
-
Alternative Name
- CATR1
Target
-
You are here:
